{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:10:54Z","timestamp":1790759454385,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00428-024-04018-w","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T22:09:29Z","timestamp":1736546969000},"page":"189-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Updates on Langerhans cell histiocytosis and other histiocytosis in children: invited review\u2014challenges and novelties in paediatric tumours"],"prefix":"10.1007","volume":"486","author":[{"given":"Laura","family":"Galluzzo Mutti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3718-6422","authenticated-orcid":false,"given":"Jennifer","family":"Picarsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"issue":"2","key":"4018_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pbc.24367","volume":"60","author":"R Haupt","year":"2013","unstructured":"Haupt R, Minkov M, Astigarraga I, Schafer E, Nanduri V, Jubran R et al (2013) Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer 60(2):175\u2013184","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"4018_CR2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41572-021-00307-9","volume":"7","author":"KL McClain","year":"2021","unstructured":"McClain KL, Bigenwald C, Collin M, Haroche J, Marsh RA, Merad M et al (2021) Histiocytic disorders Nat Rev Dis Primers 7(1):73","journal-title":"Histiocytic disorders Nat Rev Dis Primers"},{"issue":"14","key":"4018_CR3","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/cncr.35301","volume":"130","author":"K Bielamowicz","year":"2024","unstructured":"Bielamowicz K, Dimitrion P, Abla O, Bomken S, Campbell P, Collin M et al (2024) Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer 130(14):2416\u20132439","journal-title":"Cancer"},{"issue":"2","key":"4018_CR4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/pbc.20425","volume":"46","author":"N Grois","year":"2006","unstructured":"Grois N, Potschger U, Prosch H, Minkov M, Arico M, Braier J et al (2006) Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer 46(2):228\u2013233","journal-title":"Pediatr Blood Cancer"},{"issue":"16","key":"4018_CR5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood.2019000934","volume":"135","author":"C Rodriguez-Galindo","year":"2020","unstructured":"Rodriguez-Galindo C, Allen CE (2020) Langerhans cell histiocytosis. Blood 135(16):1319\u20131331","journal-title":"Blood"},{"key":"4018_CR6","unstructured":"Picarsic J (2024) Langerhans cell histiocytosis. Histiocitic\/dendritic cell neoplasms. In: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet]. Lyon (France): International Agency for Research on Cancer. (WHO classification of tumours series, 5th ed.; vol. 11). Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/63"},{"issue":"7","key":"4018_CR7","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic\u00a0Neoplasms. Leukemia 36(7):1703\u201319","journal-title":"Leukemia"},{"key":"4018_CR8","unstructured":"Picarsic J (2022) Langerhans cell histiocytosis and related disorders. Chapter 2: Haematolymphoid disorders. Histiocytic and dendritic cell neoplasms. Langerhans cell histiocytosis and related disorders. R Alaggio Pediatric tumours (5th Edition). Lyon (France): International Agency for Research on Cancer. Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/44"},{"issue":"5","key":"4018_CR9","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jpeds.2014.07.063","volume":"165","author":"SJ Simko","year":"2014","unstructured":"Simko SJ, Garmezy B, Abhyankar H, Lupo PJ, Chakraborty R, Lim KPH et al (2014) Differentiating skin-limited and multisystem Langerhans cell histiocytosis. J Pediatr 165(5):990\u2013996","journal-title":"J Pediatr"},{"issue":"1","key":"4018_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/DAD.0000000000001255","volume":"41","author":"M Dupeux","year":"2019","unstructured":"Dupeux M, Boccara O, Frassati-Biaggi A, Helias-Rodzewicz Z, Leclerc-Mercier S, Bodemer C et al (2019) Langerhans cell histiocytoma: a benign histiocytic neoplasm of diverse lines of terminal differentiation. Am J Dermatopathol 41(1):29\u201336","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"4018_CR11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/pbc.20362","volume":"45","author":"M Minkov","year":"2005","unstructured":"Minkov M, Prosch H, Steiner M, Grois N, Potschger U, Kaatsch P et al (2005) Langerhans cell histiocytosis in neonates. Pediatr Blood Cancer 45(6):802\u2013807","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"4018_CR12","first-page":"1137","volume":"109","author":"E Cournoyer","year":"2024","unstructured":"Cournoyer E, Ferrell J, Sharp S, Ray A, Jordan M, Dandoy C et al (2024) Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders. Haematologica 109(4):1137\u20131148","journal-title":"Haematologica"},{"key":"4018_CR13","doi-asserted-by":"publisher","unstructured":"Heritier S, Emile JF, Barkaoui MA, Thomas C, Fraitag S, Boudjemaa S et al (2016) BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2015.65.9508","DOI":"10.1200\/JCO.2015.65.9508"},{"issue":"4","key":"4018_CR14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","volume":"211","author":"ML Berres","year":"2014","unstructured":"Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H et al (2014) BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med 211(4):669\u2013683","journal-title":"J Exp Med"},{"issue":"1","key":"4018_CR15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2014-12-569301","volume":"126","author":"CE Allen","year":"2015","unstructured":"Allen CE, Ladisch S, McClain KL (2015) How I treat Langerhans cell histiocytosis. Blood 126(1):26\u201335","journal-title":"Blood"},{"issue":"8","key":"4018_CR16","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.4049\/jimmunol.0902336","volume":"184","author":"CE Allen","year":"2010","unstructured":"Allen CE, Li L, Peters TL, Leung HC, Yu A, Man TK et al (2010) Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol 184(8):4557\u20134567","journal-title":"J Immunol"},{"issue":"9","key":"4018_CR17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJMra1607548","volume":"379","author":"CE Allen","year":"2018","unstructured":"Allen CE, Merad M, McClain KL (2018) Langerhans-cell histiocytosis. N Engl J Med 379(9):856\u2013868","journal-title":"N Engl J Med"},{"issue":"5","key":"4018_CR18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.hoc.2015.06.004","volume":"29","author":"BJ Rollins","year":"2015","unstructured":"Rollins BJ (2015) Genomic alterations in Langerhans Cell histiocytosis. Hematol Oncol Clin North Am 29(5):839\u2013851","journal-title":"Hematol Oncol Clin North Am"},{"issue":"11","key":"4018_CR19","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","volume":"116","author":"G Badalian-Very","year":"2010","unstructured":"Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML et al (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116(11):1919\u20131923","journal-title":"Blood"},{"issue":"3","key":"4018_CR20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.14695","volume":"178","author":"S Heritier","year":"2017","unstructured":"Heritier S, Helias-Rodzewicz Z, Lapillonne H, Terrones N, Garrigou S, Normand C et al (2017) Circulating cell-free BRAF(V600E) as a biomarker in children with Langerhans cell histiocytosis. Br J Haematol 178(3):457\u2013467","journal-title":"Br J Haematol"},{"key":"4018_CR21","doi-asserted-by":"publisher","unstructured":"Wang C-J, Zhu T, Zhao C-Z, Cui H, Wang D, Zhao Z-J et al (2024) BRAF-V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first-line therapy. Pediatr Blood Cancer 71(9):e31099. https:\/\/doi.org\/10.1002\/pbc.31099","DOI":"10.1002\/pbc.31099"},{"issue":"4","key":"4018_CR22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/bloodadvances.2019032367","volume":"4","author":"LH Lee","year":"2020","unstructured":"Lee LH, Krupski C, Clark J, Wunderlich M, Lorsbach RB, Grimley MS et al (2020) High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy. Blood Adv 4(4):717\u2013727","journal-title":"Blood Adv"},{"issue":"3","key":"4018_CR23","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.3324\/haematol.2018.201194","volume":"104","author":"S Melloul","year":"2019","unstructured":"Melloul S, H\u00e9lias-Rodzewicz Z, Cohen-Aubart F, Charlotte F, Fraitag S, Terrones N et al (2019) Highly sensitive methods are required to detect mutations in histiocytoses. Haematologica 104(3):e97\u2013e99","journal-title":"Haematologica"},{"issue":"1","key":"4018_CR24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hon.2388","volume":"36","author":"LY Ballester","year":"2018","unstructured":"Ballester LY, Cantu MD, Lim KPH, Sarabia SF, Ferguson LS, Renee Webb C et al (2018) The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis. Hematol Oncol 36(1):307\u2013315","journal-title":"Hematol Oncol"},{"issue":"10","key":"4018_CR25","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/PAS.0000000000000897","volume":"41","author":"V Shanmugam","year":"2017","unstructured":"Shanmugam V, Craig JW, Hornick JL, Morgan EA, Pinkus GS, Pozdnyakova O (2017) Cyclin D1 is expressed in neoplastic cells of langerhans cell histiocytosis but not reactive Langerhans cell proliferations. Am J Surg Pathol 41(10):1390\u20131396","journal-title":"Am J Surg Pathol"},{"key":"4018_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-59632-7_1","volume-title":"Histiocytic disorders","author":"J Picarsic","year":"2018","unstructured":"Picarsic J, Jaffe R (2018) Pathology of histiocytic disorders and neoplasms and related disorders. In: Abla O, Janka G (eds) Histiocytic disorders. Springer International Publishing, Cham, pp 3\u201350"},{"issue":"22","key":"4018_CR27","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.1182\/bloodadvances.2024013545","volume":"8","author":"N Ozkaya","year":"2024","unstructured":"Ozkaya N, Melloul Benizri S, Venkataraman G, Karai LJ, Fraitag S, Razanamahery J et al (2024) Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms. Blood Adv 8(22):5796\u20135805","journal-title":"Blood Adv"},{"issue":"19","key":"4018_CR28","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.2020005209","volume":"136","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, van Halteren AGS, Lei X, Borst J, Steenwijk E, de Wit T et al (2020) Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis. Blood 136(19):2188\u20132199","journal-title":"Blood"},{"issue":"11","key":"4018_CR29","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00381-023-06108-7","volume":"39","author":"JT Mo","year":"2023","unstructured":"Mo JT, Darrow MA, Sharma JD (2023) Langerhans cell histiocytosis with aneurysmal bone cyst-like changes: a case-based literature review. Child\u2019s Nerv Syst 39(11):3057\u20133064","journal-title":"Child's Nerv Syst"},{"issue":"Pt 4","key":"4018_CR30","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/brain\/awh403","volume":"128","author":"N Grois","year":"2005","unstructured":"Grois N, Prayer D, Prosch H, Lassmann H (2005) Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 128(Pt 4):829\u2013838","journal-title":"Brain"},{"issue":"12","key":"4018_CR31","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/cncr.31348","volume":"124","author":"KL McClain","year":"2018","unstructured":"McClain KL, Picarsic J, Chakraborty R, Zinn D, Lin H, Abhyankar H et al (2018) CNS Langerhans cell histiocytosis: common hematopoietic origin for LCH-associated neurodegeneration and mass lesions. Cancer 124(12):2607\u20132620","journal-title":"Cancer"},{"issue":"5","key":"4018_CR32","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41591-021-01304-x","volume":"27","author":"C Bigenwald","year":"2021","unstructured":"Bigenwald C, Le Berichel J, Wilk CM, Chakraborty R, Chen ST, Tabachnikova A et al (2021) BRAF(V600E)-induced senescence drives Langerhans cell histiocytosis pathophysiology. Nat Med 27(5):851\u2013861","journal-title":"Nat Med"},{"key":"4018_CR33","doi-asserted-by":"crossref","unstructured":"Wilk CM, Cathomas F, T\u00f6r\u00f6k O, Berichel JL, Park MD, Heaton GR et al (2023) Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration. bioRxiv. 2023.10.10.561744","DOI":"10.1101\/2023.10.10.561744"},{"issue":"7","key":"4018_CR34","doi-asserted-by":"crossref","first-page":"e29115","DOI":"10.1002\/pbc.29115","volume":"68","author":"X Carrere","year":"2021","unstructured":"Carrere X, Pinto N, Gene Olaciregui N, Galluzzo L, Rossetti E, Celis Passini V et al (2021) High prevalence of BRAF(V600E) in patients with cholestasis, sclerosing cholangitis or liver fibrosis secondary to Langerhans cell histiocytosis. Pediatr Blood Cancer 68(7):e29115","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"4018_CR35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.hoc.2015.06.001","volume":"29","author":"J Picarsic","year":"2015","unstructured":"Picarsic J, Jaffe R (2015) Nosology and pathology of langerhans cell histiocytosis. Hematol Oncol Clin North Am 29(5):799\u2013823","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6\u20137","key":"4018_CR36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clinre.2011.03.012","volume":"35","author":"M Abdallah","year":"2011","unstructured":"Abdallah M, G\u00e9n\u00e9reau T, Donadieu J, Emile JF, Chazouill\u00e8res O, Gaujoux-Viala C et al (2011) Langerhans\u2019 cell histiocytosis of the liver in adults. Clin Res Hepatol Gastroenterol 35(6\u20137):475\u2013481","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"4018_CR37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10024-003-9876-z","volume":"7","author":"R Jaffe","year":"2004","unstructured":"Jaffe R (2004) Liver involvement in the histiocytic disorders of childhood. Pediatr Dev Pathol 7(3):214\u2013225","journal-title":"Pediatr Dev Pathol"},{"issue":"4","key":"4018_CR38","first-page":"370","volume":"12","author":"KJ Kaplan","year":"1999","unstructured":"Kaplan KJ, Goodman ZD, Ishak KG (1999) Liver involvement in Langerhans\u2019 cell histiocytosis: a study of nine cases. Mod Pathol 12(4):370\u2013378","journal-title":"Mod Pathol"},{"key":"4018_CR39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.humpath.2019.04.005","volume":"89","author":"M Kambouchner","year":"2019","unstructured":"Kambouchner M, Emile JF, Copin MC, Coulomb-Lhermin\u00e9 A, Sabourin JC, Della Valle V et al (2019) Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAF(V600E) mutation study from the French national cohort. Hum Pathol 89:51\u201361","journal-title":"Hum Pathol"},{"key":"4018_CR40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-3-319-59632-7_17","volume-title":"Histiocytic disorders","author":"F Ceppi","year":"2018","unstructured":"Ceppi F, Abla O (2018) Juvenile xanthogranuloma and related non-LCH disorders. In: Abla O, Janka G (eds) Histiocytic disorders. Springer International Publishing, Cham, pp 293\u2013311"},{"issue":"1","key":"4018_CR41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.pas.0000147395.01229.06","volume":"29","author":"D Janssen","year":"2005","unstructured":"Janssen D, Harms D (2005) Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry. Am J Surg Pathol 29(1):21\u201328","journal-title":"Am J Surg Pathol"},{"key":"4018_CR42","volume-title":"WHO classification of tumors haematolymphoid tumours","author":"R Alaggio","year":"2024","unstructured":"Alaggio R (2024) Juvenile xanthogranuloma. In: Chan J (ed) WHO classification of tumors haematolymphoid tumours, 5th edn. International Agency for Research on Cancer, Lyon","edition":"5"},{"key":"4018_CR43","doi-asserted-by":"publisher","unstructured":"Picarsic J, Jaffe R (2018) Pathology of histiocytic disorders and neoplasms and related disorders. In: Abla OJGe (ed). Histiocytic Disorders, Springer, pp 3\u201350. https:\/\/doi.org\/10.1007\/978-3-319-59632-7_1","DOI":"10.1007\/978-3-319-59632-7_1"},{"issue":"5","key":"4018_CR44","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000372-199610000-00008","volume":"18","author":"BW Zelger","year":"1996","unstructured":"Zelger BW, Sidoroff A, Orchard G, Cerio R (1996) Non-Langerhans cell histiocytoses. A new unifying concept. Am J Dermatopathol. 18(5):490\u2013504","journal-title":"Am J Dermatopathol."},{"key":"4018_CR45","unstructured":"Haynes ESE, Guo H, Jaffe R, Picarsic J (eds) (2017) S100 Immunohistochemistry in 65 localized juvenile xanthogranuloma family lesions: understanding staining patterns with clinicopathologic correlation. Spring 2017 Meeting of the Society for Pediatric Pathology. Pediatric and Developmental Pathology, San Antonio"},{"issue":"1","key":"4018_CR46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s40478-019-0811-6","volume":"7","author":"J Picarsic","year":"2019","unstructured":"Picarsic J, Pysher T, Zhou H, Fluchel M, Pettit T, Whitehead M et al (2019) BRAF V600E mutation in juvenile xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease. Acta Neuropathol Commun 7(1):168","journal-title":"Acta Neuropathol Commun"},{"issue":"13","key":"4018_CR47","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood.2023020569","volume":"142","author":"F Pegoraro","year":"2023","unstructured":"Pegoraro F, Mazzariol M, Trambusti I, Bakhshi S, Mallick S, Dunkel IJ et al (2023) Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patients. Blood 142(13):1167\u20131171","journal-title":"Blood"},{"issue":"2","key":"4018_CR48","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.2021013338","volume":"139","author":"PG Kemps","year":"2022","unstructured":"Kemps PG, Picarsic J, Durham BH, H\u00e9lias-Rodzewicz Z, Hiemcke-Jiwa L, van den Bos C et al (2022) ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood 139(2):256\u2013280","journal-title":"Blood"},{"issue":"12","key":"4018_CR49","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","volume":"25","author":"BH Durham","year":"2019","unstructured":"Durham BH, Lopez Rodrigo E, Picarsic J, Abramson D, Rotemberg V, De Munck S et al (2019) Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nat Med 25(12):1839\u20131842","journal-title":"Nat Med"},{"issue":"11","key":"4018_CR50","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/cup.14510","volume":"50","author":"B Umphress","year":"2023","unstructured":"Umphress B, Kuhar M, Kowal R, Alomari AK, Baldridge LA, Ross AJ et al (2023) NTRK expression is common in xanthogranuloma and is associated with the solitary variant. J Cutan Pathol 50(11):991\u20131000","journal-title":"J Cutan Pathol"},{"key":"4018_CR51","doi-asserted-by":"publisher","unstructured":"(2023) Abstracts from the 39th Annual Meeting of the Histiocyte Society. Pediatric Blood Cancer 70(S7):e30714. https:\/\/doi.org\/10.1002\/pbc.30714","DOI":"10.1002\/pbc.30714"},{"key":"4018_CR52","doi-asserted-by":"publisher","unstructured":"Chakraborty R, Hampton OA, Abhyankar H, Zinn DJ, Grimes A, Skull B et al (2017) Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.17521","DOI":"10.18632\/oncotarget.17521"},{"issue":"13","key":"4018_CR53","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/bloodadvances.2020001890","volume":"4","author":"SS Eissa","year":"2020","unstructured":"Eissa SS, Clay MR, Santiago T, Wu G, Wang L, Shulkin BL et al (2020) Dasatinib induces a dramatic response in a child with refractory juvenile xanthogranuloma with a novel MRC1-PDGFRB fusion. Blood Adv 4(13):2991\u20132995","journal-title":"Blood Adv"},{"issue":"22","key":"4018_CR54","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"JF Emile","year":"2016","unstructured":"Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J et al (2016) Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127(22):2672\u201381","journal-title":"Blood"},{"key":"4018_CR55","volume-title":"WHO classification of tumours haematolymphoid tumours","author":"J Chan","year":"2024","unstructured":"Chan J (2024) ALK positive histiocytosis. In: Coupland SE (ed) WHO classification of tumours haematolymphoid tumours, 5th edn. International Agency for Research on Cancer, Lyon","edition":"5"},{"issue":"7","key":"4018_CR56","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2008-03-147017","volume":"112","author":"JK Chan","year":"2008","unstructured":"Chan JK, Lamant L, Algar E, Delsol G, Tsang WY, Lee KC et al (2008) ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy. Blood 112(7):2965\u20132968","journal-title":"Blood"},{"issue":"5","key":"4018_CR57","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/1093526617740784","volume":"21","author":"H Huang","year":"2018","unstructured":"Huang H, Gheorghe G, North PE, Suchi M (2018) Expanding the phenotype of ALK-positive histiocytosis: a report of 2 cases. Pediatr Dev Pathol 21(5):449\u2013455","journal-title":"Pediatr Dev Pathol"},{"issue":"5","key":"4018_CR58","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","volume":"32","author":"KTE Chang","year":"2019","unstructured":"Chang KTE, Tay AZE, Kuick CH, Chen H, Algar E, Taubenheim N et al (2019) ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion. Mod Pathol 32(5):598\u2013608","journal-title":"Mod Pathol"},{"issue":"6","key":"4018_CR59","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/PAS.0000000000000611","volume":"40","author":"KJ Busam","year":"2016","unstructured":"Busam KJ, Vilain RE, Lum T, Busam JA, Hollmann TJ, Saw RP et al (2016) Primary and metastatic cutaneous melanomas express ALK through alternative transcriptional initiation. Am J Surg Pathol 40(6):786\u2013795","journal-title":"Am J Surg Pathol"},{"key":"4018_CR60","unstructured":"Ventana ALK (DF53) CDx assay. Available from: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/p140025c.pdf"},{"issue":"26","key":"4018_CR61","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","volume":"131","author":"O Abla","year":"2018","unstructured":"Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF et al (2018) Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood 131(26):2877\u20132890","journal-title":"Blood"},{"key":"4018_CR62","unstructured":"Natkunam Y (2024) Rosai-Dorfman disease. International Agency for Research on Cancer, Lyon. Available from: https:\/\/tumourclassification.iarc.who.int\/chaptercontent\/63\/98"},{"key":"4018_CR63","doi-asserted-by":"publisher","unstructured":"Abla O, Picarsic J (2017) Pathology of histiocytic disorders and neoplasms and related disorders. In: AOaJG (eds) Histiocytic disorders. Springe International Publishing, pp 339\u201360. https:\/\/doi.org\/10.1007\/978-3-319-59632-7_19","DOI":"10.1007\/978-3-319-59632-7_19"},{"issue":"2","key":"4018_CR64","doi-asserted-by":"crossref","first-page":"e1000833","DOI":"10.1371\/journal.pgen.1000833","volume":"6","author":"NV Morgan","year":"2010","unstructured":"Morgan NV, Morris MR, Cangul H, Gleeson D, Straatman-Iwanowska A, Davies N et al (2010) Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease. PLoS Genet 6(2):e1000833","journal-title":"PLoS Genet"},{"key":"4018_CR65","doi-asserted-by":"publisher","unstructured":"Ruby KN, Deng AC, Zhang J, LeBlanc RE, Linos KD, Yan S (2018) Emperipolesis and S100 expression may be seen in cutaneous xanthogranulomas: a multi-institutional observation. J Cutan Pathol. https:\/\/doi.org\/10.1111\/cup.13285","DOI":"10.1111\/cup.13285"},{"issue":"6","key":"4018_CR66","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/bjh.16006","volume":"186","author":"E Baraban","year":"2019","unstructured":"Baraban E, Sadigh S, Rosenbaum J, Van Arnam J, Bogusz AM, Mehr C et al (2019) Cyclin D1 expression and novel mutational findings in Rosai-Dorfman disease. Br J Haematol 186(6):837\u2013844","journal-title":"Br J Haematol"},{"key":"4018_CR67","doi-asserted-by":"publisher","unstructured":"Razanamahery J, Diamond EL, Cohen-Aubart F, Plate KH, Lourida G, Charlotte F et al (2020) Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1. Haematologica 105(1):e5\u2013e8. https:\/\/doi.org\/10.3324\/haematol.2019.216937","DOI":"10.3324\/haematol.2019.216937"},{"issue":"12","key":"4018_CR68","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/bloodadvances.2019000093","volume":"3","author":"R Mastropolo","year":"2019","unstructured":"Mastropolo R, Close A, Allen SW, McClain KL, Maurer S, Picarsic J (2019) BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor. Blood Adv 3(12):1848\u20131853","journal-title":"Blood Adv"},{"key":"4018_CR69","doi-asserted-by":"publisher","unstructured":"(2023) Abstracts from the 38th Annual Meeting of the Histiocyte Society Held Virtually and In Person in Stockholm, Sweden from September 18\u201320, 2022. Pediatric Blood Cancer 70(S1):e30097. https:\/\/doi.org\/10.1002\/pbc.30097","DOI":"10.1002\/pbc.30097"},{"key":"4018_CR70","doi-asserted-by":"publisher","unstructured":"Milne P, Bigley V, Bacon CM, Neel A, McGovern N, Bomken S et al (2017) Hematopoietic origin of Langerhans cell histiocytosis and Erdheim Chester disease in adults. Blood. https:\/\/doi.org\/10.1182\/blood-2016-12-757823","DOI":"10.1182\/blood-2016-12-757823"},{"issue":"2","key":"4018_CR71","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1182\/blood-2016-12-757377","volume":"130","author":"BH Durham","year":"2017","unstructured":"Durham BH, Roos-Weil D, Baillou C, Cohen-Aubart F, Yoshimi A, Miyara M et al (2017) Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem\/progenitor cells. Blood 130(2):176\u2013180","journal-title":"Blood"},{"issue":"10","key":"4018_CR72","doi-asserted-by":"crossref","first-page":"100268","DOI":"10.1016\/j.modpat.2023.100268","volume":"36","author":"A Ravindran","year":"2023","unstructured":"Ravindran A, Dasari S, Ruan GJ, Artymiuk CJ, He R, Viswanatha DS et al (2023) Malignant histiocytosis comprises a phenotypic spectrum that parallels the lineage differentiation of monocytes, macrophages, dendritic cells, and Langerhans cells. Mod Pathol 36(10):100268","journal-title":"Mod Pathol"},{"issue":"5","key":"4018_CR73","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ajh.27263","volume":"99","author":"GJ Ruan","year":"2024","unstructured":"Ruan GJ, Zanwar S, Ravindran A, Schram S, Abeykoon JP, Hazim A et al (2024) Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis. Am J Hematol 99(5):871\u2013879","journal-title":"Am J Hematol"},{"issue":"3","key":"4018_CR74","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2350\/09-03-0622-OA.1","volume":"13","author":"EC Castro","year":"2010","unstructured":"Castro EC, Blazquez C, Boyd J, Correa H, de Chadarevian JP, Felgar RE et al (2010) Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature. Pediatr Dev Pathol 13(3):225\u2013237","journal-title":"Pediatr Dev Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-04018-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-024-04018-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-04018-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T01:31:34Z","timestamp":1738200694000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-024-04018-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4018"],"URL":"https:\/\/doi.org\/10.1007\/s00428-024-04018-w","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}